Tags

Type your tag names separated by a space and hit enter

[Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Med Klin. 1978 May 26; 73(21):791-7.MK

Abstract

26 patients suffering from arterial occlusive disease in the legs, stages IIa to IV according to Fontaine classification, and 7 patients with serious vascular disorders in the arm, were treated with daily 3- to 4 X 1 tablet Trental 400 (400 mg Pentoxifylline per tablet) over extended periods. In order to establish the therapeutic efficacy of the drug, influence on microcirculation (133Xenon-muscle clearance), poststenotic blood pressure (Doppler ultrasonic technique), oscillography, walking distance and alteration of clinical stage (following Fontaine classification) were studied. The medication resulted in a significant increase in muscular capillary flow whereby more affected legs showed better response than those initially less impaired. The poststenotic pressure increased significantly in initially more affected arteries and elevation of oscillographic amplitudes was found, too. The walking distance increased markedly, rest pain was removed and the clinical stage according to Fontaine classification changed on a linear scale from the more severe to the light stages of impairment. The patients with vascular disorders in the arms showed good improvement of their condition.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

651768

Citation

Angelkort, B, and E Doppelfeld. "[Treatment of Chronic Arterial Occlusive Disease. Clinical Study With a New Galenic Preparation of Pentoxifyllin (Trental 400) (author's Transl)]." Medizinische Klinik, vol. 73, no. 21, 1978, pp. 791-7.
Angelkort B, Doppelfeld E. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)]. Med Klin. 1978;73(21):791-7.
Angelkort, B., & Doppelfeld, E. (1978). [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)]. Medizinische Klinik, 73(21), 791-7.
Angelkort B, Doppelfeld E. [Treatment of Chronic Arterial Occlusive Disease. Clinical Study With a New Galenic Preparation of Pentoxifyllin (Trental 400) (author's Transl)]. Med Klin. 1978 May 26;73(21):791-7. PubMed PMID: 651768.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)]. AU - Angelkort,B, AU - Doppelfeld,E, PY - 1978/5/26/pubmed PY - 2000/3/22/medline PY - 1978/5/26/entrez SP - 791 EP - 7 JF - Medizinische Klinik JO - Med Klin VL - 73 IS - 21 N2 - 26 patients suffering from arterial occlusive disease in the legs, stages IIa to IV according to Fontaine classification, and 7 patients with serious vascular disorders in the arm, were treated with daily 3- to 4 X 1 tablet Trental 400 (400 mg Pentoxifylline per tablet) over extended periods. In order to establish the therapeutic efficacy of the drug, influence on microcirculation (133Xenon-muscle clearance), poststenotic blood pressure (Doppler ultrasonic technique), oscillography, walking distance and alteration of clinical stage (following Fontaine classification) were studied. The medication resulted in a significant increase in muscular capillary flow whereby more affected legs showed better response than those initially less impaired. The poststenotic pressure increased significantly in initially more affected arteries and elevation of oscillographic amplitudes was found, too. The walking distance increased markedly, rest pain was removed and the clinical stage according to Fontaine classification changed on a linear scale from the more severe to the light stages of impairment. The patients with vascular disorders in the arms showed good improvement of their condition. SN - 0025-8458 UR - https://www.unboundmedicine.com/medline/citation/651768/[Treatment_of_chronic_arterial_occlusive_disease__Clinical_study_with_a_new_galenic_preparation_of_Pentoxifyllin__Trental_400___author's_transl_]_ DB - PRIME DP - Unbound Medicine ER -